Cite
PO-1868: In silico hypofractionation feasibility study for lymph node oligometastases SBRT on the MRI-linac.
MLA
Winkel, D., et al. “PO-1868: In Silico Hypofractionation Feasibility Study for Lymph Node Oligometastases SBRT on the MRI-Linac.” Radiotherapy & Oncology, vol. 152, Nov. 2020, pp. S1041–42. EBSCOhost, https://doi.org/10.1016/S0167-8140(21)01886-7.
APA
Winkel, D., Eppinga, W. S. C., Intven, M. P. W., Werensteijn-Honingh, A. M., Hes, J., Snoeren, L. M. W., Bol, G. H., Raaymakers, B. W., Jürgenliemk-Schulz, I. M., & Kroon, P. S. (2020). PO-1868: In silico hypofractionation feasibility study for lymph node oligometastases SBRT on the MRI-linac. Radiotherapy & Oncology, 152, S1041–S1042. https://doi.org/10.1016/S0167-8140(21)01886-7
Chicago
Winkel, D., W.S.C. Eppinga, M.P.W. Intven, A.M. Werensteijn-Honingh, J. Hes, L.M.W. Snoeren, G.H. Bol, B.W. Raaymakers, I.M. Jürgenliemk-Schulz, and P.S. Kroon. 2020. “PO-1868: In Silico Hypofractionation Feasibility Study for Lymph Node Oligometastases SBRT on the MRI-Linac.” Radiotherapy & Oncology 152 (November): S1041–42. doi:10.1016/S0167-8140(21)01886-7.